Disturbances of Mitochondrial Parameters to Distinguish Patients with Depressive Episode of Bipolar Disorder and Major Depressive Disorder
Overview
Authors
Affiliations
Background: Mitochondrial dysfunctions are implicated in the pathophysiology of mood disorders. We measured and examined the following selected mitochondrial parameters: citrate synthase (CS) activity, electron transport system (ETS) complex (complexes I, II, and IV) activities, and mitochondrial respiration in blood platelets.
Patients And Methods: The analyses were performed for 24 patients suffering from a depressive episode of bipolar affective disorder (BD), compared to 68 patients with MDD and 104 healthy controls. BD and unipolar depression were clinically evaluated using well-established diagnostic scales and questionnaires.
Results: The CS, complex II, and complex IV activities were decreased in the depressive episode of BD patients; complex I and complex I/CS ratio were significantly increased compared to healthy controls. We observed significantly decreased complex II and CS activities in patients suffering from MDD compared to controls. Decreased respiration after complex I inhibition and increased residual respiration were found in depressive BD patients compared to controls. Physiological respiration and capacity of the ETS were decreased, and respiration after complex I inhibition was increased in MDD patients, compared to controls. Increased complex I activity can be a compensatory mechanism for decreased CS and complex II and IV activities.
Conclusion: We can conclude that complex I and its abnormal activity contribute to the defects in cellular energy metabolism during a depressive episode of BD. The observed parameters could be used in a panel of biomarkers that could selectively distinguish BD depression from MDD and can be easily examined from blood elements.
Blood mitochondrial health markers cf-mtDNA and GDF15 in human aging.
Trumpff C, Huang Q, Michelson J, Liu C, Shire D, Habeck C bioRxiv. 2025; .
PMID: 39974983 PMC: 11838371. DOI: 10.1101/2025.01.28.635306.
Jing P, Yu H, Sun W, Liang M, Xia T, Yang H Neuropsychiatr Dis Treat. 2025; 21():15-24.
PMID: 39776895 PMC: 11705967. DOI: 10.2147/NDT.S465744.
Jing P, Yu H, Wu T, Yu B, Liang M, Xia T World J Psychiatry. 2024; 14(11):1746-1754.
PMID: 39564165 PMC: 11572673. DOI: 10.5498/wjp.v14.i11.1746.
Huang Q, Shire D, Hollis F, Abuaish S, Picard M, Monk C bioRxiv. 2024; .
PMID: 39464008 PMC: 11507865. DOI: 10.1101/2024.10.16.618719.
Bisle E, Varadarajan S, Kolassa I Brain Behav Immun Health. 2024; 38:100790.
PMID: 38974216 PMC: 11225645. DOI: 10.1016/j.bbih.2024.100790.